Leading the way to safer medication
 Crosscheck  Recommender

Botulinum toxin type A

Brand names: AZZALURE BOCOUTURE BOTOX DYSPORT JEUVEAU NEURONOX NUCEIVA VISTABEL XEOMIN

Therapeutic Indications

Botulinum toxin type A is indicated for:

Spastic quadriplegic cerebral palsy

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

Other strabismus

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

at least one of
Transient cerebral ischaemic attacks and related syndromes
Stroke, not specified as haemorrhage or infarction
and additionally
Upper limb spasticity

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

Hyperhidrosis of axilla

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intradermal

at least one of
Spasmodic torticollis
Congenital deformity of sternocleidomastoid muscle

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

at least one of
Blepharospasm
Hemifacial spasm

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intramuscular

Contraindications

Active ingredient Botulinum toxin type A is contraindicated in the following cases:

No gender/age discrimination

at least one of
Unspecified adverse effect of drug or medicament
Pregnancy
Lactation
Diseases of myoneural junction and muscle

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines

MPI, US: SPL/PLR 2021: XEOMIN Powder for solution for injection
MPI, EU: SmPC 2019: BOTOX Powder for solution for injection

< Previous: Overview
Next: Precautions >